Immediate Impact
69 standout
Citing Papers
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
2022 Standout
Works of S. Heylen being referenced
Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative study
1992
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| S. Heylen | 444 | 92 | 98 | 94 | 10 | 551 | |
| Richard M. Steinbook | 330 | 72 | 53 | 83 | 21 | 500 | |
| Uffe Juul Povlsen | 464 | 48 | 95 | 73 | 16 | 606 | |
| Philippe Bouhours | 322 | 127 | 75 | 87 | 20 | 472 | |
| Ataru Inagaki | 379 | 73 | 159 | 42 | 23 | 620 | |
| Evelyn Howanitz | 459 | 102 | 165 | 145 | 13 | 607 | |
| Umberto Micò | 320 | 93 | 92 | 60 | 19 | 542 | |
| Joseph Pultz | 290 | 81 | 56 | 46 | 11 | 515 | |
| N. Schooler | 250 | 113 | 69 | 42 | 18 | 512 | |
| Herman V. Szymanski | 266 | 62 | 151 | 64 | 19 | 528 | |
| H. De Cuyper | 325 | 272 | 61 | 66 | 14 | 593 |
All Works
Loading papers...